Comparison of primary sensitization of naive human T cells to varicella- zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 560-567

  Jenkins, Darlene E ^a   Yasukawa, Linda L ^a   Bergen, Randy ^a   Benike, Claudia ^a   Engleman, Edgar G ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHICKENPOX; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE; VACCINATION; VARICELLA ZOSTER VIRUS;

ADULT; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; CHICKENPOX VACCINE; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, NATURAL; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDES; T-LYMPHOCYTES; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS;

EID: 0032931913     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Arvin, A. M. 1995. Varicella-Zoster virus. In Virology. B. Fields, ed. Raven Press, New York, pp. 2547-2586.
2. Lungu, O., P. W. Annunziato, A. Gershon, S. M. Staugaitis, D. Josefson, P. LaRussa, and S. J. Silverstein. 1995. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc. Natl. Acad. Sci. USA 92:10980.
3. Arvin, A. M., J. F. Moffat, and R. Redman. 1996. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. In Advances in Virus Research, Vol. 46. F. A. Murphy, A. J. Shatkin, and K. Maramorosh, eds. Academic Press, San Diego, pp. 265-309.
4. Hayward, A., O. Pontesilli, M. Herberger, M. Laszlo, and M. Levin. 1986. Specific lysis of varicella-zoster virus-infected B lymphoblasts by human T cells. J. Virol. 58:179.
5. Hayward, A. R. 1990. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J. Virol. 64:651.
6. Hickling, J. K., L. K. Borysiewicz, and J. G. P. Sissons. 1987. Varicella-zoster virus specific cytotoxic T lympohcytes(TC): detection and frequency analysis of HLA class 1-restricted Tc in human peripheral blood. J. Virol. 61:3463.
7. Sharp, M., K. Terada, A. Wilson, S. Nader, P. E. Kinchington, W. Ruyechan, J. Hay, and A. M. Arvin. 1992. The kinetics and protein specificity of T-lymphocyte cytotoxicity in healthy adults immunized with live attenuated varicella vaccine. J. Infect. Dis. 165:852.
8. + phenotype. J. Immunol. 146:257.
9. Zhang, Y., M. Cosyns, M. J. Levin, and A. R. Hayward. 1994. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98:128.
10. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cell development and maturation. Adv. Exp. Med. Biol. 417:1.
11. Austyn, J. M. 1987. Lymphoid dendritic cells. Immunology 62:161.
12. Macatonia S. E., P. M. Taylor, S. C. Knight, and B. A. Askonas. 1989. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp Med. 169:1255.
13. Hauser, C., and S. I. Katz. 1988. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc. Natl. Acad. Sci. USA 85: 5625.
14. Inaba, K., and R. M. Steinman. 1985. Protein-specific helper T-lymphocyte formation initiated by dendritic cells. Science 229:475.
15. Nonacs, R., C. Humborg, J. P. Tam, and R. M. Steinman. 1992. Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J. Exp. Med. 176:519.
16. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172(2):631.
17. + CTLS from naive precursors. J. Immunol. 153:996.
18. + T cell lines from naive precursors. Eur. J. Immunol. 25: 1206.
19. Marland, G., A. B. Bakker, G. J. Aderna, and C. G. Figdor. 1996. Dendritic cells in immune response induction. Stem Cells 14:501.
20. + precursors. J. Immunol. 158: 2134.
21. + T cells. J. Clin. Invest. 94:797.
22. + cytolytic T cell responses. J. Exp. Med., 182:1663.
23. Sallusto F., M. Cella, C. Danieli, and A. Lanzauecchia 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulalion by cytokines and bacterial products. J. Exp. Med. 182:389.
24. Zhu, Z., M. D. Gershon, R. Ambron, C. Gabel, and A. A. Gershon. 1994. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc. Natl. Acad. Sci. USA 92:3546.
25. + T-cell immune responses induced by dendrilic cells. Immunology 85:467.
26. + T cells and process soluble antigen. J. Immunol. 155:5427.
27. + T cells. J. Immunol. 155:4915.
28. Rescigno, M., C. Winzler, D. Delia, C. Mutini, M. Lutz, and P. Ricciardi-Castagnoli. 1997. Dendritic cell maturation is required for initiation of the immune response. J. Leukocyte Biol. 61:415.
29. Kinchington, P. R., J. K. Houghland, A. M. Arvin, W. T. Ruyechan, and J. Hay. 1992 Varicella zoster virus IE62 protein is a major virion component. J. Virol. 66:359.
30. Bergen, R. E., P. S. Diaz, and A. M. Arvin. 1990. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J. Infect. Dis. 162:1049.
31. Bergen, R. E., M. Sharp, A. Sanchez, A. K. Judd, and A. M. Arvin. 1991. Human T Cells recognize multiple eptiopes of a major tegument/immediate early protein (IE62) and glycoprotein 1 of varicella-zoster virus. Viral Immunol. 4:151.
32. Centers for Disease Control. 1996. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. Morbid. Mortal. Wkly. Rep. 45:1.
33. Margalit H., J. L. Spouge, J. L. Cornette, K. B. Cease, C. Delisi, and J. A. Berzofsky. 1987. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J. Immunol. 138:2213.
34. Rothbard, J. B., and W. R. Taylor. 1988. A sequence pattern common to T cell epitopes. EMBO J. 7:93.
35. Clarke, P., A. Brunschwig, and D. H. Gilden. 1997. DNA sequence of a simian varicella virus gene that encodes a homologue of varicella zoster virus IE62 and herpes simplex virus. Virology 1:45.
36. Gray, W. L., N. J. Gusick, C. Ek-Kommonen, S. E. Kempson, and T. M. Fletcher III. 1995. The inverted repeat regions of the simian varicella virus and varicella-zoster virus genomes have a similar genetic organization. Virus Res. 39:181.
37. Schuler, G., B. Thurner, and N. Romani. 1997. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int. Arch. Allergy Immunol. 112: 317.
38. + T-cell lines specific for HIV gp120. J. Acquired Immune Defic: Syndr. 7:15.
39. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
40. Quaki, I. A., J. Currier, A. Fell, D. W. Taylor, T. Roberts, R. A. Houghten, R. D. England, J. A. Berzofsky, L. H. Miller, and M. F. Good. 1994. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. J. Immunol. 153:2082.
41. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
42. Cella M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
43. Jenkins, D. E., R. L. Redman, E. M. Lam, C. Liu, I. Lin, and A. M. Arvin. 1998. IL-10, IL-12 and IFN-γ production in primary and memory immune responses to varicella-zoster virus. J. Infect. Dis. 178:940.
44. O'Doherty, U., R. M. Steinman, M. Peng, P. U. Cameron, S. Gezelter, I. Kopeloff, and W. J. Swiggard. 1993. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med. 178:1067.
45. Sipsas, N. V., S. A. Kalams, A. Trocha, S. He, W. A. Blattner, B. D. Walker, and R. P. Johnson. 1997. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1. J. Clin. Invest. 99:752.
46. + T cell recognition of influenza A virus hemagglutinin after subunit vaccination. J. Virol. 70:4784.
47. Moulon, C., J. Peguet-Navarro, P. Courtellemont, G. Redziniak, and D. Schmitt. 1993. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. Immunology 80:373.
48. Hickman, C. J., A. S. Khan, P. A. Rota, and W. J. Bellini. 1997. Use of synthetic peptides to identify measles nucleoprotein T-cell epitopes in vaccinated and naturally infected humans. Virology 235:386.
49. Arnon, R., and R. J. Horwitz. 1992. Synthetic peptides as vaccines. Curr. Opin. Immunol. 4:449.
50. Obeid, O. E., C. D. Partidos, C. R. Howard, and M. W. Steward. 1995. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol. 69:1420.